TWiV 829: Antiviral and cytotoxically empowered for COVID-19
b'
A TWiV duo reviews how SARS-CoV-2 attacks the olfactory mucosa but spares the olfactory bulb, vaccination with BNT162b2 induces virus-specific stem cell memory T cells, and development of an oral protease inhibitor for the treatment of COVID-19.
Hosts:\\xa0Vincent Racaniello and Brianne Barker
Subscribe (free):\\xa0iTunes,\\xa0Google Podcasts,\\xa0RSS,\\xa0email
Become a\\xa0patron\\xa0of\\xa0TWiV!
Links for this episode
- How SARS-CoV-2 attacks olfactory mucosa (Cell)
- SARS-CoV-2-specific stem cell memory T cells after mRNA vaccine (Sci Immunol)
- Oral SARS-CoV-2 protease inhibitor (Science)
- Paxlovid phase 2/3 trial preliminary results (Pfizer)
- Letters read on TWiV 829
- Timestamps by Jolene. Thanks!
Weekly Picks
Brianne \\u2013 Coronavirus Neutralizing Antibodies and mRNA Vaccine Video
Vincent \\u2013 MHC restriction of cytotoxic T cell lysis (Nobel description)
Listener Picks
Lisa \\u2013 Shall Furnish Medicine
Bistra \\u2013 Saving the World by Julia Alvarez
Intro music is by\\xa0Ronald Jenkees
Send your virology questions and comments to twiv@microbe.tv